Holds 2 active US DMFs for daptomycin, filing since 2015. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for daptomycin, filing since 2015. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for daptomycin, filing since 2019. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for daptomycin, filing since 2015. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for daptomycin, filing since 2025. Its GMP is recognised in 1 market.
Holds 2 active US DMFs for daptomycin, filing since 2016.
Registered with SFDA (Saudi Arabia) for daptomycin. Its GMP is recognised in 1 market.
This page filters the worldwide Daptomycin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for daptomycin and what filings they hold.
Chat with Fred, your AI analyst